POELLATH advises Life Science Valley on the launch of the Life Science Valley Fund

Life Science Valley Ventures Management GmbH has successfully placed the Life Science Valley Growth Fund for the early-stage financing of life science start-ups in Lower Saxony. The investor base includes the state of Lower Saxony, the biotechnology group Sartorius and the University Medical Center Göttingen. The fund is initially endowed with around EUR 12 million in venture capital and will expand to up to EUR 20 million by attracting further investors. The focus of the investments is on science-based start-ups located in Lower Saxony in the fields of biotechnology, medical technology, digital health, data science and drug development.

The fund is managed by Göttingen-based Life Science Valley Ventures Management GmbH, whose managing directors are investor and multiple founder Marco Janezic and experienced industry expert Dr. Sven Wagner.

POELLATH advised Life Science Valley on all contractual, regulatory and tax aspects of the fund structuring, contractual documentation and negotiations with investors with the following Berlin team:

• Dr. Philip Schwarz van Berk (partner, lead, private funds)
• Katharina Hammer (associate, private funds)